Itaconate is a metabolic regulator of mitochondrial homeostasis and pancreatic necrosis in acute pancreatitis

Itaconate, an immunometabolite generated by the mitochondrial metabolic enzyme immune-responsive gene 1 (IRG1), exhibits anti-inflammatory effects. However, its specific role in acinar cell injury in acute pancreatitis (AP) remains unclear. Using an integrated multi-omics approach, this study aimed to systematically investigate the dynamic changes in itaconate metabolism in AP. The effects of itaconate metabolism on mitochondrial homeostasis and pyroptosis in in vivo and in vitro AP models were assessed via transmission electron microscopy, confocal laser scanning microscopy, and western blot analysis. Multi-transcriptomics analyses were conducted to screen for key downstream regulatory factors of itaconate metabolism and were validated in in vivo and in vitro experiments. Finally, human pancreatitis tissue microarrays were used to validate clinical relevance. Significantly elevated IRG1 expression was observed in injured acinar cells from pancreatic tissues of both AP patients and mouse models of AP. Functional experiments demonstrated that both endogenous IRG1 overexpression and exogenous 4-OI supplementation significantly maintained mitochondrial homeostasis and inhibited gasdermin D-mediated pyroptosis, thereby ameliorating pancreatic necrosis in AP. Mechanistically, integrated multi-transcriptome analysis identified thioredoxin-interacting protein (TXNIP) as a downstream negative regulator of IRG1/itaconate, whose overexpression exacerbated mitochondrial dysfunction and pancreatic necrosis in AP. These findings reveal that the IRG1/itaconate/TXNIP signaling axis constitutes the core mechanism for improving pancreatic necrosis in AP by regulating mitochondrial homeostasis and suppressing acinar cell pyroptosis. Our data further extend the critical regulatory function of itaconate metabolism in non-immune cells, providing a solid theoretical foundation for developing novel metabolic therapeutic strategies for AP based on the IRG1/itaconate pathway.

Authors

Institutions

Publication Details

Journal
Cellular & Molecular Biology Letters
Published
2026-11-16
DOI
https://doi.org/10.1186/s11658-026-01050-3
Primary Topic
Pancreatitis Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Itaconate is a metabolic regulator of mitochondrial homeostasis and pancreatic necrosis in acute pancreatitis

乔伟光, Jinqiang Zhuang, Xin Gao, Bo Tu et al.
4 links
Cellular & Molecular Biology Letters
Pancreatitis Pathology and Treatment
article

Itaconate is a metabolic regulator of mitochondrial homeostasis and pancreatic necrosis in acute pancreatitis

乔伟光, Jinqiang Zhuang, Xin Gao, Bo Tu, Weiming Xiao, Xiaowu Dong, Mingyan Wang, Keyan Wu, Xingmeng Xu, Yanbing Ding, Jiajia Pan, Qingtian Zhu, Lianghao Hu, Xinyi Liu, Lin Chen, Weijuan Gong, Wei Li, Zhihao Wang
article en

Abstract

Itaconate, an immunometabolite generated by the mitochondrial metabolic enzyme immune-responsive gene 1 (IRG1), exhibits anti-inflammatory effects. However, its specific role in acinar cell injury in acute pancreatitis (AP) remains unclear. Using an integrated multi-omics approach, this study aimed to systematically investigate the dynamic changes in itaconate metabolism in AP. The effects of itaconate metabolism on mitochondrial homeostasis and pyroptosis in in vivo and in vitro AP models were assessed via transmission electron microscopy, confocal laser scanning microscopy, and western blot analysis. Multi-transcriptomics analyses were conducted to screen for key downstream regulatory factors of itaconate metabolism and were validated in in vivo and in vitro experiments. Finally, human pancreatitis tissue microarrays were used to validate clinical relevance. Significantly elevated IRG1 expression was observed in injured acinar cells from pancreatic tissues of both AP patients and mouse models of AP. Functional experiments demonstrated that both endogenous IRG1 overexpression and exogenous 4-OI supplementation significantly maintained mitochondrial homeostasis and inhibited gasdermin D-mediated pyroptosis, thereby ameliorating pancreatic necrosis in AP. Mechanistically, integrated multi-transcriptome analysis identified thioredoxin-interacting protein (TXNIP) as a downstream negative regulator of IRG1/itaconate, whose overexpression exacerbated mitochondrial dysfunction and pancreatic necrosis in AP. These findings reveal that the IRG1/itaconate/TXNIP signaling axis constitutes the core mechanism for improving pancreatic necrosis in AP by regulating mitochondrial homeostasis and suppressing acinar cell pyroptosis. Our data further extend the critical regulatory function of itaconate metabolism in non-immune cells, providing a solid theoretical foundation for developing novel metabolic therapeutic strategies for AP based on the IRG1/itaconate pathway.

Cellular & Molecular Biology Letters
Jiangsu University (CN), Toho University (JP), Fred Hutch Cancer Center (US), Nanfang Hospital (CN), Changhai Hospital (CN), Northern Jiangsu People's Hospital (CN), Southern Medical University (CN), Yangzhou University (CN)
Good health and well-being
Pancreatitis Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon